Spero Therapeutics's market cap is currently $106.36M. The company's EPS TTM is $-0.03; its P/E ratio is 10.83; Spero Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
